BERTOLOTTI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 27.014
AS - Asia 13.001
EU - Europa 12.331
SA - Sud America 1.761
Continente sconosciuto - Info sul continente non disponibili 341
AF - Africa 251
OC - Oceania 32
Totale 54.731
Nazione #
US - Stati Uniti d'America 26.498
SG - Singapore 4.143
IT - Italia 3.519
CN - Cina 3.496
GB - Regno Unito 3.131
HK - Hong Kong 1.567
BR - Brasile 1.308
VN - Vietnam 1.231
DE - Germania 1.030
SE - Svezia 955
FI - Finlandia 783
BD - Bangladesh 606
UA - Ucraina 587
FR - Francia 534
TR - Turchia 482
RU - Federazione Russa 462
PL - Polonia 388
KR - Corea 328
CA - Canada 323
IN - India 247
BG - Bulgaria 228
NL - Olanda 206
ID - Indonesia 168
AR - Argentina 166
IQ - Iraq 104
JP - Giappone 102
MX - Messico 94
ES - Italia 86
IE - Irlanda 73
EC - Ecuador 69
PK - Pakistan 59
ZA - Sudafrica 59
BE - Belgio 54
AE - Emirati Arabi Uniti 53
VE - Venezuela 53
AT - Austria 51
MA - Marocco 50
CO - Colombia 47
MY - Malesia 46
CL - Cile 45
PH - Filippine 44
UZ - Uzbekistan 43
TW - Taiwan 39
SA - Arabia Saudita 36
CH - Svizzera 34
CZ - Repubblica Ceca 32
IR - Iran 29
AU - Australia 26
JO - Giordania 25
LT - Lituania 25
PE - Perù 25
ET - Etiopia 24
TH - Thailandia 24
EG - Egitto 23
PY - Paraguay 21
CR - Costa Rica 20
DZ - Algeria 19
GR - Grecia 19
RO - Romania 19
TN - Tunisia 19
KE - Kenya 16
UY - Uruguay 16
NP - Nepal 15
OM - Oman 15
TT - Trinidad e Tobago 13
PT - Portogallo 12
AZ - Azerbaigian 11
BY - Bielorussia 11
IL - Israele 11
PA - Panama 11
SI - Slovenia 11
BO - Bolivia 10
HN - Honduras 10
JM - Giamaica 9
MK - Macedonia 9
NG - Nigeria 9
NI - Nicaragua 9
RS - Serbia 9
DO - Repubblica Dominicana 8
EU - Europa 8
SK - Slovacchia (Repubblica Slovacca) 8
SY - Repubblica araba siriana 8
AL - Albania 7
GT - Guatemala 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LU - Lussemburgo 7
MD - Moldavia 7
PS - Palestinian Territory 7
BH - Bahrain 6
DK - Danimarca 6
HU - Ungheria 6
KW - Kuwait 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
SN - Senegal 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
CY - Cipro 5
LB - Libano 5
Totale 54.327
Città #
Singapore 2.784
Santa Clara 2.439
Fairfield 2.378
Ashburn 2.344
Southend 2.013
Hong Kong 1.544
Woodbridge 1.496
Chandler 1.322
Houston 1.316
Jacksonville 1.044
Hefei 984
San Jose 952
Seattle 892
Dearborn 830
Wilmington 825
Ann Arbor 820
Cambridge 788
Beijing 634
Helsinki 577
London 573
Nyköping 571
Chicago 568
Los Angeles 518
Ho Chi Minh City 404
Modena 387
Warsaw 370
New York 331
Seoul 315
The Dalles 305
San Diego 298
Council Bluffs 297
Milan 295
Hanoi 281
Izmir 278
Princeton 242
Sofia 216
Salt Lake City 197
Eugene 187
Lauterbourg 186
Buffalo 166
Shanghai 163
Rome 154
Moscow 143
Munich 131
Dallas 128
São Paulo 125
Tampa 117
Bologna 111
Elk Grove Village 111
Toronto 109
Des Moines 108
Jakarta 104
Boardman 84
Fremont 83
Orem 79
Tokyo 79
Frankfurt am Main 75
Redwood City 75
Guangzhou 71
Columbus 70
Dublin 62
Haiphong 62
Bremen 57
Grafing 57
Da Nang 55
Brooklyn 54
Falls Church 54
Montreal 53
Sterling 53
Phoenix 52
Naples 50
Baghdad 49
Denver 45
Brussels 44
Florence 44
Parma 43
North York 40
Turku 40
Atlanta 39
Lancaster 39
San Mateo 39
Nuremberg 38
Turin 38
Amsterdam 36
San Francisco 36
Mountain View 35
Chennai 34
Kunming 34
Miami 34
Tashkent 34
Norwalk 33
Kent 32
Nanjing 32
Padova 32
Manchester 31
Mexico City 31
Boston 30
Broomfield 30
Palermo 27
Reggio Emilia 27
Totale 36.742
Nome #
MoCA 7.1: Multicenter Validation of the First Italian Version of Montreal Cognitive Assessment 1.073
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 713
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 468
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 453
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 449
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 431
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 431
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 427
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 410
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 408
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 403
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 385
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 383
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 380
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 380
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 378
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 375
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 374
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 371
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 370
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 365
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 363
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 362
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 362
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 361
Physical exercise for late life depression: effects on cognition and disability 361
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 357
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 356
Telomere length elongation after weight loss intervention in obese adults 348
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 344
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 343
Endocrine and liver interaction: the role of endocrine pathways in NASH 342
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 340
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 339
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 339
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 336
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report 334
Effects of cholecalciferol supplementation in patients with stable heart failure and low vitamin D levels (ECSPLOIT-D). A double-blind, randomized, placebo-controlled pilot study 331
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study 329
Analgesic drug taking: Beliefs and behavior among headache patients 329
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 326
The relationship between age and fat infiltration in liver and muscle 325
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 323
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 322
Nonalcoholic fatty liver disease and aging: epidemiology to management 322
La clinica metabolica per il trattamento della lipodistrofia 319
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 314
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 312
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 309
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 309
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 306
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 305
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 303
Risk of birth defects associated with maternal pregestational diabetes. 303
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 300
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 295
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 293
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 292
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 292
Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation. 289
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 288
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 287
Advances in the comprehension of the pathophysiology of bile secretion 286
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 284
Effects of acute changes of bile acid pool composition on biliary lipid secretion 283
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 281
Review article: effect of bile salt pool composition on hepatic and biliary functions 281
Olanzapine metabolic side effects: a weight gain issue? 281
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 280
Liver X receptors and copper metabolism: New frontiers for the oxysterol receptors 277
Disposition of naproxen after oral administration during and between migraine attacks. 273
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 271
Anatomia e fisiologia delle vie biliari 271
Bile acid structure and regulation of biliary protein secretion and composition in man 269
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention 269
Case of an old man with aortic dissection type A and enlarging meningioma 268
Effect of ursocholic acid on bile lipid secretion and composition 267
The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo 266
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 263
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 263
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 261
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 261
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 260
Review article: hyperlipidaemia and cardiovascular risk 258
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 256
Nonalcoholic fatty liver disease induced by leuprorelin acetate 256
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 254
Hypertensive disease in the elderly: Predictors of clinical evolution in a follow-up study 254
REGULATION OF HEPATIC CHOLESTEROL-METABOLISM IN THE RAT IN-VIVO. EFFECT OF A SYNTHETIC FAT-FREE DIET ON STEROL SYNTHESIS AND LOW-DENSITY-LIPOPROTEIN TRANSPORT 252
PHARMACOKINETIC OF REDUCED GLUTATHIONE IN MAN - EFFECT ON PLASMA CYSTEINE AND THIOL COMPOUNDS 251
Influence of age and sex on serum concentrations of total dimeric activin A 249
Drug-Induced Liver Injury - Types and Phenotypes 249
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 248
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy 248
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 245
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 245
Risk communication at the time of Coronavirus: are we washing our hand of COVID-19? 245
Heart failure and chronic kidney disease in a registry of internal medicine wards 242
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 241
Associated factors to post-operative delirium in patients with hip fractures: an orthogeriatric experience. 241
Totale 32.686
Categoria #
all - tutte 211.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.377 183 479 311 389 101 218 314 266 552 243 808 513
2022/20233.991 417 361 312 350 448 576 102 430 510 74 218 193
2023/20242.853 128 163 184 271 527 231 366 339 103 111 135 295
2024/20258.969 320 152 215 638 1.816 1.277 587 444 876 449 972 1.223
2025/202618.278 996 697 1.426 2.152 3.209 1.669 1.946 842 1.671 1.423 1.316 931
2026/2027623 623 0 0 0 0 0 0 0 0 0 0 0
Totale 54.731